From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
VTR · NYSE · Health Care REITs
Health Care REITs company based in Chicago, Illinois.
In the last 90 days, no insider of Ventas reported an open-market purchase and 0 open-market sales. Members of Congress disclosed 1 trade in its stock. The latest 13F reports cover the quarter ending Jun 30, 2026. Every figure links to its official SEC, House, Senate or USAspending record.
Last close, Oct 5, 2026
$81.36
Adjusted for splits and dividends
Last 12 months
+16.6%
S&P 500 +15.8% over the same dates
Market value
$41.7B
Last close × shares outstanding
Bets against the stock: 19.8M shares sold short (3.9% of shares outstanding), -2.9% vs the previous count, 6.2 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$1.73B
+21.7% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
—
Debt —, cash $199M, at Jun 30, 2026
Net income, last 12 months
—
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 29, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$5.83B
+18.5% vs the year before
Net income
Not reported
As reported in the annual filing
Shares outstanding
513M
As of Jul 28, 2026
In fiscal 2025 the company spent $860M on dividends. Cash actually paid, from its cash-flow statement.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
2 different filers disclosed VTR within 90 days. Disclosed 116 days after the transaction; reported as an official range, not an exact amount.
Stock since the trade +2.9% · S&P 500 +2.7% · to Oct 5
A board member of Ventas paid $197K out of pocket for Ventas shares. The Ventas shares held grew by 15%.
Director sold ~$104K of Ventas
Scheduled in advanceStock since the trade -5.0% · S&P 500 +12.0% · to Oct 5
Ventas's and GC sold $3.02M of Ventas shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $69.25 on Oct 6, 2025 to $81.36 on Oct 5, 2026 (+17.5%). Disclosed activity in the last 12 months: 1 insider purchase, 26 insider sales (25 under pre-arranged plans), 2 Congress purchases, 1 Congress sale, 0 fund reports of opening or adding and 1 fund report of trimming or selling out (13F, quarter-end snapshots).
JPMORGAN CHASE & CO.
Schedule 13G: passive · filed Jul 27, 2026 · 42.6M shares
Vanguard Portfolio Management
Schedule 13G: passive · filed Apr 29, 2026 · 41.3M shares
Vanguard Capital Management
Schedule 13G: passive · filed Apr 30, 2026 · 35.9M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Top officer leaving
“and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”).”
3 insiders sold ~$47.1M in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Short sale volume: 62.2% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 57.3%. FINRA daily files, to Oct 5, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.